GC
SPPI

Globeflex Capital’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Globeflex Capital’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-121,918
Closed -$740K – 606
2015
Q1 		$740K Sell
121,918
-21,496
-15% -$143K 0.14% 262
2014
Q4 		$994K Buy
143,414
+57
+0% +$419 0.19% 217
2014
Q3 		$1.17M Buy
143,357
+121,957
+570% +$954K 0.13% 182
2014
Q2 		$173K Buy
+21,400
New +$162K 0.02% 373
2013
Q3 		– Sell
-76,600
Closed -$571K – 679
2013
Q2 		$571K Buy
+76,600
New +$588K 0.08% 275

Other funds holding SPPI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Globeflex Capital's SPPI Position: Q2 2015 in Review

Globeflex Capital sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2015, closing a stake of 121,918 shares — an estimated $740K sold.

Globeflex Capital first reported a position in SPPI in Q2 2013 and held it in 5 quarters. The position peaked at $1.17M in Q3 2014. 128 funds tracked by Wall St. Rank hold SPPI as of Q2 2015.

  • Globeflex Capital reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2015 after selling out during the quarter.
  • Globeflex Capital sold 121,918 Spectrum Pharmaceuticals Inc shares in Q2 2015, an estimated $740K.
  • Globeflex Capital first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 5 quarters.
  • Globeflex Capital's Spectrum Pharmaceuticals Inc position peaked at $1.17M in Q3 2014.
  • 128 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2015.

Based on Globeflex Capital's 13F filing for Q2 2015, filed 5 Aug 2015.